Arvinas, Inc. (ARVN)

11.73 -0.17 (-1.43%) USD  |  NASDAQ  |  Dec 30, 16:00
11.92 +0.19 (+1.62%) Pre-Market: 08:03
More

Arvinas EV to Revenues

EV to Revenues Chart

View EV to Revenues for ARVN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to Revenues Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EV to Revenues Range, Past 5 Years

View EV to Revenues Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to Revenues Benchmarks

View EV to Revenues Benchmarks
Start Trial
Pfizer Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Verastem, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade
Genprex, Inc. --

EV to Revenues Related Metrics

EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade